Cargando…
ANCA-associated vasculitis following Oxford-AstraZeneca COVID-19 vaccine in Brazil: Is there a causal relationship? A case report
This article presents a case of rapidly progressive glomerulonephritis following the Oxford-AstraZeneca COVID-19 vaccine in a female patient 58 years old. After 5 days, she presented fatigue, paleness, arthralgia on hands, knees, ankles, foamy urine, and elevated blood pressure. Exams showed serum c...
Autores principales: | Zamoner, Welder, Scardini, Julia Baldon, De Dio, Bruna Jordana, Marques, Amanda de Melo, Silva, Vanessa dos Santos, Garcia, Aline Lutz, dos Santos, Daniela Cristina, Viero, Rosa Marlene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582333/ https://www.ncbi.nlm.nih.gov/pubmed/36275808 http://dx.doi.org/10.3389/fmed.2022.1003332 |
Ejemplares similares
-
A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?
por: Villa, Miguel, et al.
Publicado: (2021) -
Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021) -
Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021) -
Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine
por: Katsouli, Olga K., et al.
Publicado: (2023) -
Monoarthritis induced by the Oxford-AstraZeneca(R) SARS-CoV-2 vaccine
por: Schoenardie, Bruna Ossanai, et al.
Publicado: (2022)